Nitinol catheter Market Growth Qualitative Analysis and Forecast 2032
Nitinol catheter Market by Type (Vascular Catheter, Cardiac Catheter, Other), Application (Hospitals, Clinics, Ambulatory Surgery Centers, Others), and Region (North America, Europe, Asia Pacific, South America, Middle East and Africa), Global trends and forecast from 2022 to 2032
Categories: Food & Beverages
Format : 
Nitinol is an alloy of nickel and titanium that represents a unique class of shape memory alloys. In the healthcare industry, it is rapidly being chosen for the configuration of various medical devices. It has various technical properties such as shape memory effect, super elasticity and high cushioning. Nitinol is widely used to make catheter tubes, guidewires, filters, needles, dental files and other surgical instruments.
Nitinol catheter Market is projected to reach USD US$ 15,807.53 million in 2020 to USD 27,327.25 million by 2032, at a CAGR of 8.5 % during the period 2022-2032
The advantages of minimally invasive surgery (MIS), such as smaller incisions, less pain, fewer complications, less blood loss, and shorter hospital stays, are having a dramatic impact on the adoption of minimally invasive surgery (MIS). The increasing adoption of minimally invasive surgery (MIS) is primarily driven by the benefits of minimally invasive surgery (MIS), as well as capitalizing on the growth of Nitinol catheter Market, especially for robotic and laparoscopic surgery. It's helpful.
Recent Development
Terumo Announces PRIZER, a New Study Investigating Dual Layer Technology in Patients with FemPop Lesions
LEUVEN, BELGIUM - August 3, 2020 - Terumo Europe N.V., a leading medical device company, announces the initiation of a new Post-market study: the Prospective, Multicenter, Post-market, Single aRm study, to confIrm the performance of the RenZan™ Peripheral Stent System in treating subjects with SupErficial Femoral and/or Popliteal aRtery disease (PRIZER).
- In April 2022, Endosmart announced its partnership with Chamfr to provide nitinol components for medical devices through the partnership, engineers can order selected nitinol braids, shape-set tubes and wires and grinder wires from Chamfr.
- In January 2017, Abbott Laboratories acquired St. Jude Medical (SJM). The acquisition of St. Jude Medical will advance the company’s revenue growth is cardiovascular care and neuromodulation devices. The company is also focusing on developing new designs for Supera self?expanding nitinol stent system used in the treatment of peripheral artery disease.
- In October 2016, Medtronic's CoreValve Evolut R 34 mm valve received the U.S. Food and Drug Administration (FDA) approval. The system delivers a greater opportunity to treat patients with smaller vessels through the preferred transfemoral access route.
- In August 2016, W.L. Gore and Associates, Inc. announced the U.S. Food and Drug Administration (FDA) approval for the GORE TIGRIS Vascular Stent, a dual-component stent with a unique fluoropolymer/nitinol design. This will improve anatomical conformability with the natural movement of the knee when treating peripheral artery disease (PAD)
- In December 2015, Boston Scientific Corporation acquired the interventional radiology portfolio of CeloNova Biosciences (CeloNova). The acquisition includes drug-eluting microspheres, which can be used for delivery of chemotherapy drugs to cancerous tumors and uterine fibroids.
| Report Data | Nitinol catheter Market |
| Nitinol catheter Market CAGR 2022 - 2032 | 8.5% |
| Nitinol catheter Market Analysis Period | 2022 - 2032 |
| Nitinol catheter Market Base Year | 2021 |
| Nitinol catheter Market Forecast Data | 2022 - 2032 |
| Segments Covered | By Type, By Application, And by Regions |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | B. Braun Melsungen, Boston Scientific, C. R. Bard, Zimmer Biomet Holdings, Cook Medical, Arthrex, Terumo, Medtronic, Abbott Laboratories, W. L. Gore & Associates, Endosmart GmbH |
| Report Coverage | Market Drivers, Market Trends, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
| Key market Segments | Nitinol catheter Market by Type • Vascular Catheter • Cardiac Catheter • Other Nitinol catheter Market by Applications • Hospitals • Clinics • Ambulatory Surgery Centers • Others |
Frequently Asked Questions
What is the future market value of the Nitinol Catheter Market?
The current market value for Nitinol Catheter Market is expected USD 27,327.25 million by 2032.
What is the CAGR of the Market?
The Nitinol Catheter Market is to grow at a CAGR of 8.5% during the forecast by 2029.
What is the Market segment?
On the basis of type, the Nitinol Catheter Market is segmented by Type (Vascular Catheter, Cardiac Catheter, Other).
Who are the key players operating in the Nitinol Catheter Market?
The major players operating in the Nitinol Catheter Market are B. Braun Melsungen, Boston Scientific, C. R. Bard, Zimmer Biomet Holdings, Cook Medical, Arthrex, Terumo, Medtronic, Abbott Laboratories, W. L. Gore & Associates, Endosmart GmbH.
Base Year:2021
Historical Data:2018-2022
No of Pages:130
Select Licence Type
Single User
Multi User
Corporate User
Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.
US $ 3500
Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.
US $ 5250
The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.
US $ 7000
Need a Discount? Get in touch with us for special pricing
Connect with our sales team
Email: [email protected]